SciBase Holding Dirección

Dirección controles de criterios 3/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Pia Renaudin

Chief Executive Officer (CEO)

SEK 648.0k

Compensación total

Porcentaje del salario del CEO	77.8%
Permanencia del CEO	less than a year
Participación del CEO	n/a
Permanencia media de la dirección	9.5yrs
Promedio de permanencia en la Junta Directiva	7.3yrs

Actualizaciones recientes de la dirección

Recent updates

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Pia Renaudin en comparación con los beneficios de SciBase Holding?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	-SEK 56m
Dec 31 2023	SEK 648k	SEK 504k	-SEK 56m

Compensación vs. Mercado: La compensación total de Pia($USD62.10K) está por debajo de la media de empresas de tamaño similar en el mercado Swedish ($USD257.80K).

Compensación vs. Ingresos: Datos insuficientes para comparar la compensación de Pia con los resultados de la empresa.

CEO

Pia Renaudin (57 yo)

less than a year

Permanencia

SEK 648,000

Compensación

Ms. Pia Renaudin serves as Chief Executive Officer at SciBase Holding AB (publ) since October 01, 2023 SciBaseHe served as Chief Executive Officer at Senzime AB (publ) since February 08, 2019 until May 03,...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Pia Renaudin	Chief Executive Officer	less than a year	SEK 648.00k	sin datos
Stig Ollmar	Founder & Chief Scientific Officer	26.5yrs	sin datos	sin datos
Michael Colérus	Chief Financial Officer	10.5yrs	SEK 272.54k	sin datos
Per Svedenhag	Head of Business Development & Marketing	9.5yrs	SEK 1.43m	sin datos
Tobias Bergenblad	Global Sales Director	9.5yrs	sin datos	sin datos
Leda Beaty	Head of US Commercial Operations	less than a year	sin datos	sin datos

9.5yrs

Permanencia media

62yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de SCIB es experimentado (9.4 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Thomas Taapken	Independent Director	7.2yrs	SEK 150.00k	sin datos
Matt Leavitt	Independent Director	3.2yrs	SEK 150.00k	sin datos
Per Nordberg	Deputy Director	7.5yrs	sin datos	sin datos
Jesper Hoiland	Chairman of the Board	less than a year	sin datos	sin datos
Allan Halpern	Member of Scientific Advisory Board	9.3yrs	sin datos	sin datos
Scott Menzies	Member of Scientific Advisory Board	9.3yrs	sin datos	sin datos
Diana Ferro	Independent Director	7.2yrs	SEK 150.00k	sin datos
David Elder	Member of Scientific Advisory Board	9.3yrs	sin datos	sin datos
Josep Malvehy	Member of Scientific Advisory Board	9.3yrs	sin datos	sin datos
Holger Hänßle	Member of Scientific Advisory Board	9.3yrs	sin datos	sin datos
Robert Molander	Director	less than a year	sin datos	sin datos
Jvalini Dwarkasing	Independent Director	2.8yrs	SEK 150.00k	sin datos

7.3yrs

Permanencia media

61.5yo

Promedio de edad

Junta con experiencia: La junta directiva de SCIB se considera experimentada (8.3 años de antigüedad promedio).

SciBase Holding Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

SciBase Holding AB (publ) Appoints Leda Beaty as Head of US Commercial Operations

SciBase Holding AB (publ), Annual General Meeting, May 17, 2024

SciBase Holding AB (publ) Appoints Nomination Committee

Chairman & Interim CEO recently bought kr534k worth of stock

Scibase Appoints Pia Renaudin as Chief Executive Officer

SciBase Holding AB (publ) Announces Executive Changes

Recent updates

SciBase Holding AB (publ) Appoints Leda Beaty as Head of US Commercial Operations

Consensus EPS estimates upgraded to kr0.22 loss, revenue downgraded

New minor risk - Profitability

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Forecast to breakeven in 2026

New major risk - Shareholder dilution

Scibase Announces the Launch of Ebarrier Score, the First Ai-Driven Skin Barrier Assessment Tool for Research and Cosmetic Testing

New minor risk - Shareholder dilution

Price target decreased by 13% to kr1.68

SciBase Holding AB (publ) has completed a Composite Units Offering.

Consensus EPS estimates upgraded to kr0.27 loss

Consensus revenue estimates fall by 11%

New major risk - Financial position

Full year 2023 earnings: EPS and revenues miss analyst expectations

Price target decreased by 39% to kr4.30

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

SciBase Holding AB (publ) to Report Fiscal Year 2023 Results on Feb 21, 2024

SciBase Holding AB (publ) to Report Q1, 2024 Results on May 09, 2024

SciBase Holding AB (publ), Annual General Meeting, May 17, 2024

SciBase Holding AB (publ) Appoints Nomination Committee

New major risk - Market cap size

SciBase Holding AB Announces the Publication of A Collaborative Scientific Project with the Swiss Institute of Allergy and Asthma Research in Davos, Switzerland

Chairman & Interim CEO recently bought kr534k worth of stock

Scibase Appoints Pia Renaudin as Chief Executive Officer

Consensus EPS estimates fall by 33%

Second quarter 2023 earnings: EPS and revenues miss analyst expectations

SciBase Holding AB (publ) Announces Executive Changes

Full year 2022 earnings: EPS misses analyst expectations

Consensus EPS estimates upgraded to kr0.30 loss, revenue downgraded

Full year 2022 earnings: EPS misses analyst expectations

SciBase Holding AB (publ) to Report Nine Months, 2023 Results on Nov 10, 2023

Price target decreased to kr11.00

SciBase Holding AB (publ) to Report Fiscal Year 2022 Results on Feb 23, 2023

SciBase Holding AB (publ) Announces New Study Shows Nevisense Significantly Improves US Clinician's Decision-Making Beyond Dermoscopy

SciBase Holding AB (publ), Annual General Meeting, May 18, 2023

Is SciBase Holding (STO:SCIB) In A Good Position To Deliver On Growth Plans?

SciBase Holding AB Announces Nevisense Detects Skin Barrier Damage in Mice Caused by Household Detergents

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

SciBase Holding AB (publ) to Report Q3, 2022 Results on Nov 10, 2022

SciBase Holding AB (publ) Announces US Study Shows That EIS and Nevisense Significantly Improves Clinicians' Diagnostic Accuracy

Will SciBase Holding (STO:SCIB) Spend Its Cash Wisely?

SciBase Holding AB (publ) Study Shows Clinical Benefit of Nevisense

Full year 2021 earnings released: kr0.67 loss per share (vs kr1.12 loss in FY 2020)

CEO & President recently bought kr76k worth of stock

Independent Chairman recently bought kr504k worth of stock

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Chief Financial Officer recently bought kr111k worth of stock

Third quarter 2021 earnings released: kr0.13 loss per share (vs kr0.20 loss in 3Q 2020)

We're Hopeful That SciBase Holding (STO:SCIB) Will Use Its Cash Wisely

Second quarter 2021 earnings released: kr0.19 loss per share (vs kr0.38 loss in 2Q 2020)

SciBase Holding AB (publ) announced that it has received SEK 71.214109 million in funding from Van Herk Investments B.V., Ostvast Capital Management Limited, and other investors

First quarter 2021 earnings released: kr0.15 loss per share (vs kr0.54 loss in 1Q 2020)

Scibase Receives Important European MDR Certification

SciBase Holding AB (publ) Submits First Reimbursement Application to CMS in Florida

Is SciBase Holding (STO:SCIB) In A Good Position To Deliver On Growth Plans?

David Melin Resigns as Head of Product Development of SciBase AB

Full year 2020 earnings released: kr1.12 loss per share (vs kr2.38 loss in FY 2019)

Revenue beats expectations

SciBase Holding AB (publ) to Report Q3, 2021 Results on Nov 11, 2021

Calculating The Intrinsic Value Of SciBase Holding AB (publ) (STO:SCIB)

SciBase Holding AB (publ) Announces New Study Published Validating Further Nevisense Indication, Non-Melanoma Skin Cancer

New 90-day high: kr4.85

Third quarter 2020 earnings released: kr0.20 loss per share

SciBase Holding AB (publ) to Report Fiscal Year 2020 Results on Feb 19, 2021

Scibase Holding AB (Publ) Announces Positive Step for US Reimbursement of Nevisense

SciBase Holding Releases Next Generation Platform, Nevisense Go

New 90-day high - kr4.14

Earnings released

Análisis de compensación del CEO